Over 10 years experience of Traceability Solutions
By pharmatrax
Category: Technoloy
No Comments Drug Target Review explores the latest applications of stem cells in modeling disease, drug production and the most recent steps in regenerative medicine provided by…
By pharmatrax
Category: News
No Comments You’re unwell, you see a doctor, they prescribe you a medicine… and you take it. But how exactly is that drug having an effect? What is its…
By pharmatrax
Category: Technoloy
No Comments This is what Europe’s biggest corporations got up to this week in innovation. By Maija Palmer CES roundup CES calls itself the “stage for innovation”…
By pharmatrax
Category: News
No Comments The FDA has added at least three additional items to its growing roster of heartburn drug recalls. The onslaught of new recalls were announced between…
By pharmatrax
Category: News
No Comments WASHINGTON D.C. — Mylan Pharmaceuticals is conducting a voluntary recall of three lots of Nizatidine Capsules, according to the U.S. Food & Drug Administration (FDA).…
By pharmatrax
Category: Technoloy
No Comments Understanding the promise of AI in pharma supply chain management. Artificial Intelligence (AI) is a game-changing technology, for all industries, not just pharmaceuticals. Over the…
By pharmatrax
Category: Technoloy
No Comments It’s amazing how a single entity can impact almost every aspect of an entire industry, especially something as large as the pharmaceutical industry. Yet, the…
By pharmatrax
Category: Technoloy
No Comments The U.S. Food and Drug Administration (FDA) has issued approval for patient-specific airway stents made with 3D printing. The custom stents, which are used to…
By pharmatrax
Category: News
No Comments The company is making the agency’s open-source MyStudies platform available, enabling for easier access to data for research into new medications, devices and more. Google…
By pharmatrax
Category: Technoloy
No Comments Advances in AI and cloud technologies are helping health and pharmaceutical companies improve services, but they come with regulatory challenges. Let’s look at how smart…